Two sides of the same coin? Unraveling subtle differences between human embryonic and induced pluripotent stem cells by Raman spectroscopy
De Angelis, Maria Teresa
Coluccio, Maria Laura
De Vitis, Stefania
Di Fabrizio, Enzo M.
KAUST DepartmentMaterials Science and Engineering Program
Physical Sciences and Engineering (PSE) Division
Permanent link to this recordhttp://hdl.handle.net/10754/626288
MetadataShow full item record
AbstractBackground: Human pluripotent stem cells, including embryonic stem cells and induced pluripotent stem cells, hold enormous promise for many biomedical applications, such as regenerative medicine, drug testing, and disease modeling. Although induced pluripotent stem cells resemble embryonic stem cells both morphologically and functionally, the extent to which these cell lines are truly equivalent, from a molecular point of view, remains controversial. Methods: Principal component analysis and K-means cluster analysis of collected Raman spectroscopy data were used for a comparative study of the biochemical fingerprint of human induced pluripotent stem cells and human embryonic stem cells. The Raman spectra analysis results were further validated by conventional biological assays. Results: Raman spectra analysis revealed that the major difference between human embryonic stem cells and induced pluripotent stem cells is due to the nucleic acid content, as shown by the strong positive peaks at 785, 1098, 1334, 1371, 1484, and 1575 cm–1, which is enriched in human induced pluripotent stem cells. Conclusions: Here, we report a nonbiological approach to discriminate human induced pluripotent stem cells from their native embryonic stem cell counterparts.
CitationParrotta E, De Angelis MT, Scalise S, Candeloro P, Santamaria G, et al. (2017) Two sides of the same coin? Unraveling subtle differences between human embryonic and induced pluripotent stem cells by Raman spectroscopy. Stem Cell Research & Therapy 8. Available: http://dx.doi.org/10.1186/s13287-017-0720-1.
SponsorsThis research was supported in part by a grant from the Programma Operativo Nazionale 2007/2013: iCARE (Infrastruttura Calabrese per la Medicina Rigenerativa: Generazione di Biobanche per la Preservazione di Cellule Staminali Umane e di Tessuto Osseo per Uso Clinico e Design e Sviluppo di Bioscaffold Innovativi) (PON03PE_00009_2) and by the Programma Operativo Nazionale 2007/2013 PON: “Exchanger: Share Your Science” (PON04a3_00433).
JournalStem Cell Research & Therapy
Except where otherwise noted, this item's license is described as This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
- Authors: Chen F, Zhang G, Yu L, Feng Y, Li X, Zhang Z, Wang Y, Sun D, Pradhan S
- Issue date: 2016 Jul 30
- Generation of Human Induced Pluripotent Stem Cells Using RNA-Based Sendai Virus System and Pluripotency Validation of the Resulting Cell Population.
- Authors: Chichagova V, Sanchez-Vera I, Armstrong L, Steel D, Lako M
- Issue date: 2016
- An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
- Authors: Menon S, Shailendra S, Renda A, Longaker M, Quarto N
- Issue date: 2016 Jan 21
- Skin Biopsy and Patient-Specific Stem Cell Lines.
- Authors: Li Y, Nguyen HV, Tsang SH
- Issue date: 2016
- Generation and Characterization of Patient-Specific Induced Pluripotent Stem Cell for Disease Modeling.
- Authors: Sivapatham R, Zeng X
- Issue date: 2016